CANCER OF UNKNOWN PRIMARY
Clinical trials for CANCER OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new CANCER OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for CANCER OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: CANCER OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
Blood test could unlock hidden treatment paths for mysterious cancers
Knowledge-focused Recruiting nowThis study looks at whether a simple blood test can help find genetic changes in cancer of unknown primary (CUP), a type of cancer where doctors don't know where it started. About 100 adults with CUP will give blood samples to test for DNA mutations that might point to new treatm…
Matched conditions: CANCER OF UNKNOWN PRIMARY
Sponsor: The Christie NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 26, 2026 08:58 UTC